Antibody Patent

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

PatentsGlobal

Strategic Antibody Patent Characterisation Shapes Enforcement and Validity in Brazil

Patent practitioners in Brazil must carefully consider antibody characterisation in patent applications, as the Brazilian Patent and Trademark Office (BPTO) requires precise structural definitions that impact claim scope, enablement, and enforcement. Lessons from the US Supreme Court’s 2023 Amgen v Sanofi decision und…

Thursday, September 10, 2026

PatentsUSA

US Jury Orders Amgen to Pay $20.2 Million in Antibody Patent Infringement Case

A US jury has ruled that Amgen must pay $20.2 million in damages for infringing an antibody patent. The verdict underscores ongoing patent enforcement challenges in the biopharmaceutical sector, highlighting the high stakes involved in antibody-related intellectual property disputes.

Friday, June 12, 2026

Newsletters & Digests

Follow Antibody Patent

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Explore

All coverage Filtered archive